AMI ORGANICS
Quarterly Results Analysis [Dec2023]
AMI ORGANICS Quarterly Results
Consolidated | Dec2023 Audited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹166 Cr | ₹172 Cr | ₹142 Cr | ₹186 Cr | ₹152 Cr | ₹147 Cr | ₹131 Cr | ₹144 Cr |
Expenses | ₹140 Cr | ₹148 Cr | ₹117 Cr | ₹146 Cr | ₹122 Cr | ₹119 Cr | ₹108 Cr | ₹118 Cr |
Operating Income | ₹27 Cr | ₹25 Cr | ₹25 Cr | ₹41 Cr | ₹31 Cr | ₹28 Cr | ₹23 Cr | ₹26 Cr |
Other Income | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹0 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr |
Interest | ₹3 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
Depreciation | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
Profit Before Tax | ₹24 Cr | ₹-10 Cr | ₹22 Cr | ₹37 Cr | ₹30 Cr | ₹26 Cr | ₹20 Cr | ₹22 Cr |
Profit After Tax | ₹18 Cr | ₹-17 Cr | ₹17 Cr | ₹27 Cr | ₹22 Cr | ₹19 Cr | ₹15 Cr | ₹21 Cr |
EPS | ₹4.54 | ₹-5.11 | ₹4.57 | ₹7.46 | ₹6.12 | ₹5.22 | ₹4.08 | ₹5.84 |
Industry Peers & Returns | 1W | 1M | 1Y |
AMI ORGANICS | 0.2% | 4.4% | 20.6% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
AMI ORGANICS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -3.43 % |
Y-o-Y | 9.25 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹166 Cr | -3.43 | |
Sep2023 | ₹172 Cr | 21.08 | |
Jun2023 | ₹142 Cr | -23.62 | |
Mar2023 | ₹186 Cr | 22.33 | |
Dec2022 | ₹152 Cr | 3.65 | |
Sep2022 | ₹147 Cr | 12.20 | |
Jun2022 | ₹131 Cr | -8.73 | |
Mar2022 | ₹144 Cr | - |
AMI ORGANICS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 6.83 % |
Y-o-Y | -13.91 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹27 Cr | 6.83 | |
Sep2023 | ₹25 Cr | -1.34 | |
Jun2023 | ₹25 Cr | -38.44 | |
Mar2023 | ₹41 Cr | 32.68 | |
Dec2022 | ₹31 Cr | 9.49 | |
Sep2022 | ₹28 Cr | 22.69 | |
Jun2022 | ₹23 Cr | -11.11 | |
Mar2022 | ₹26 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 10.63 % |
Y-o-Y | -21.18 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 15.93% | 10.63 | |
Sep2023 | 14.4% | -18.51 | |
Jun2023 | 17.67% | -19.39 | |
Mar2023 | 21.92% | 8.46 | |
Dec2022 | 20.21% | 5.65 | |
Sep2022 | 19.13% | 9.31 | |
Jun2022 | 17.5% | -2.62 | |
Mar2022 | 17.97% | - |
AMI ORGANICS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | Positive |
Y-o-Y | -20.07 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹18 Cr | Positive | |
Sep2023 | ₹-17 Cr | Negative | |
Jun2023 | ₹17 Cr | -38.79 | |
Mar2023 | ₹27 Cr | 22.07 | |
Dec2022 | ₹22 Cr | 17.05 | |
Sep2022 | ₹19 Cr | 28.08 | |
Jun2022 | ₹15 Cr | -30.16 | |
Mar2022 | ₹21 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | Positive |
Y-o-Y | -26.81 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 10.7 % | Positive | |
Sep2023 | -9.87 % | Negative | |
Jun2023 | 11.7 % | -19.81 | |
Mar2023 | 14.59 % | -0.21 | |
Dec2022 | 14.62 % | 12.90 | |
Sep2022 | 12.95 % | 14.10 | |
Jun2022 | 11.35 % | -23.47 | |
Mar2022 | 14.83 % | - |
AMI ORGANICS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | Positive |
Y-o-Y | -25.82 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹4.54 | Positive | |
Sep2023 | ₹-5.11 | Negative | |
Jun2023 | ₹4.57 | -38.74 | |
Mar2023 | ₹7.46 | 21.90 | |
Dec2022 | ₹6.12 | 17.24 | |
Sep2022 | ₹5.22 | 27.94 | |
Jun2022 | ₹4.08 | -30.14 | |
Mar2022 | ₹5.84 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD